Gestational Trophoblastic Disease: Current Evaluation and Management
Gestational Trophoblastic Disease: Current Evaluation and Management
Published On: 28 May, 2022 1:32 PM | Updated On: 15 May, 2024 11:57 AM
Gestational Trophoblastic Disease: Current Evaluation and Management
The Majority of the women suffering from any form of gestational trophoblastic disease can be successfully diagnosed and treated with preservation of their reproductive function.
Managing molar pregnancies properly is crucial in diminishing the acute complications and identifying postmolar gestational trophoblastic neoplasia quickly.
Individualizing treatment for women suffering from any form of gestational trophoblastic neoplasia is crucial. This individualization must be based on known risk factors, usage of less-toxic therapy for patients with low-risk diseases and aggressive multiagent therapy for those with high-risk diseases.
Only the centers or consultants having experience in the complex multimodality treatment must manage Patients with high-risk gestational trophoblastic neoplasia.
SOURCE- Soper JT. Gestational Trophoblastic Disease: Current Evaluation and Management [published correction appears in Obstet Gynecol. 2022 Jan 1;139(1):149]. Obstet
Gynecol. 2021;137(2):355-370. doi:10.1097/AOG.0000000000004240
Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks
Please login to comment on this article